Segment disclosures

Company overview

GFR PHARMACEUTICALS INC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

2 dimension combinations 24 retained observations 8 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Extraction Business

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=gfrp:ExtractionBusinessMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-03-31195652 USD20130514Open filing evidence
2012-01-01 – 2012-12-31926158 USD20130329Open filing evidence
2012-07-01 – 2012-09-30250563 USD20121114Open filing evidence
2012-01-01 – 2012-09-30712966 USD20121114Open filing evidence
2012-04-01 – 2012-06-30237897 USD20120810Open filing evidence
2012-01-01 – 2012-06-30462403 USD20120810Open filing evidence
2012-01-01 – 2012-03-31224506 USD20130514Open filing evidence
2011-01-01 – 2011-12-31953013 USD20130329Open filing evidence
2011-07-01 – 2011-09-30182269 USD20121114Open filing evidence
2011-01-01 – 2011-09-30675760 USD20121114Open filing evidence
2011-04-01 – 2011-06-30199867 USD20120810Open filing evidence
2011-01-01 – 2011-06-30493491 USD20120810Open filing evidence

Medical Business

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=gfrp:MedicalBusinessMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-03-31610121 USD20130514Open filing evidence
2012-01-01 – 2012-12-313345636 USD20130329Open filing evidence
2012-07-01 – 2012-09-30815566 USD20121114Open filing evidence
2012-01-01 – 2012-09-302465957 USD20121114Open filing evidence
2012-04-01 – 2012-06-30960051 USD20120810Open filing evidence
2012-01-01 – 2012-06-301650391 USD20120810Open filing evidence
2012-01-01 – 2012-03-31690340 USD20130514Open filing evidence
2011-01-01 – 2011-12-313721276 USD20130329Open filing evidence
2011-07-01 – 2011-09-30989854 USD20121114Open filing evidence
2011-01-01 – 2011-09-302652218 USD20121114Open filing evidence
2011-04-01 – 2011-06-301022966 USD20120810Open filing evidence
2011-01-01 – 2011-06-301662364 USD20120810Open filing evidence